
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer. Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -4.035 | -10.9870660313 | 36.725 | 38.42 | 32.68 | 735991 | 35.72596267 | CS |
4 | -11.11 | -25.3652968037 | 43.8 | 46.095 | 32.68 | 838682 | 39.12648169 | CS |
12 | -36.11 | -52.4854651163 | 68.8 | 71.71 | 32.68 | 1189342 | 51.86326066 | CS |
26 | -13.69 | -29.517033204 | 46.38 | 71.71 | 32.68 | 888094 | 50.55005165 | CS |
52 | 17.17 | 110.631443299 | 15.52 | 71.71 | 14.835 | 904189 | 48.31370416 | CS |
156 | 15.48 | 89.9477048228 | 17.21 | 71.71 | 5.65 | 367154 | 41.84108433 | CS |
260 | -1.31 | -3.85294117647 | 34 | 71.71 | 5.65 | 328730 | 40.12772017 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions